Royal Oak, MINCT06465745Now EnrollingIRB Ready

Mitral Regurgitation Clinical Trial in Royal Oak, MI

Access cutting-edge mitral regurgitation treatment through this clinical trial at a research site in Royal Oak. Study-provided care at no cost to qualified participants.

Sponsored by 4C Medical Technologies, Inc.

Quick Self-Assessment

See if you qualify for this Royal Oak location

Preparing your pre-screening questions…

Expert Care in Royal Oak

Access mitral regurgitation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mitral regurgitation treatment provided free

Apply for This Royal Oak Location

Check if you qualify for this mitral regurgitation clinical trial in Royal Oak, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Royal Oak

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Royal Oak site if eligible
  4. 4Begin participation

About This Mitral Regurgitation Study in Royal Oak

This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

Sponsor: 4C Medical Technologies, Inc.

Who Can Participate

Inclusion Criteria

Age ≥ 18 years.
Symptomatic New York Heart Association (NYHA) class II-IV.
Moderate-to-severe or severe MR (3+) despite optimal guideline-directed medical therapy (GDMT) as determined by an independent Echo Core Lab.
Unsuitable for surgery and Transcatheter Edge-toEdge Repair (TEER) as determined by the local site Heart Team.

Exclusion Criteria

(Abbreviated List):
Inability to understand the trial or a history of non-compliance with medical advice.
Inability to provide signed Informed Consent Form (ICF).
History of any cognitive or mental health status that would interfere with participation in the trial.
Currently enrolled in any other pre-approval investigational trial (does not apply to long-term post-market trials unless these trials might clinically interfere with the current trial endpoints (e.g., limit use of trial-required medication, etc.)).
Female subjects who are pregnant or planning to become pregnant within the trial period.
Known hypersensitivity or contraindication to heparin, or warfarin without adequate alternative medications.
Known hypersensitivity to nitinol (i.e., nickel allergy) that cannot be adequately medicated.
Known hypersensitivity to contrast media that cannot be adequately medicated.
Evidence of current left ventricular ejection fraction (LVEF) ≤ 25%.
Concurrent medical condition with a life expectancy of less than 12 months.
Transcatheter aortic repair or replacement within 90 days prior to the index procedure.
Percutaneous coronary intervention (PCI) within 90 days prior to the index procedure.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Royal Oak?

Yes, this clinical trial (NCT06465745) has an active research site in Royal Oak, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mitral Regurgitation Treatment Options in Royal Oak, MI

If you're searching for mitral regurgitation treatment options in Royal Oak, MI, this clinical trial (NCT06465745) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Royal Oak research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mitral regurgitation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mitral regurgitation clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Royal Oak, MI

See all heart attack clinical trials recruiting in Royal Oak — not just this study.

Browse Heart Attack Trials in Royal Oak →

Browse More Trials by Condition

Heart Attack TrialsValvular Heart Disease TrialsRheumatoid Arthritis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Royal Oak?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Royal Oak, MI